Performing identity: the case of the (Greek) Cypriot National Guard

Students of International Relations are taught that the modern nation-state has a monopoly on the (legitimate) use of violence. However, in the case of the Republic of Cyprus this does not seem to be the case, since its armed forces, the Cypriot National Guard (CNG), are intimately embedded within Greece’s military structure, and half the island remains under Turkish occupation. The colonization of Cyprus (1571–1960) and subsequent decolonization has led to the gradual construction of two rigid identities, Greek and Turkish, that have been institutionalized legally and imposed constitutionally. This paper seeks to answer two questions. First, how does the CNG perform and therefore constitute a ‘Greek identity’? Second, is this performance epistemically violent, hindering the formation of hybrid identities? We use autoethnography, interviews, and insights from Pierre Bourdieu’s concept of the habitus and Judith Butler’s performativity theory to explore these two questions. We argue that the CNG performs a Greek identity in three key configurations: 1) the operational link between the Greek Army and the CNG; 2) the explicit connection to both ancient and modern Greece through various CNG insignia and practices, including parades and marching songs; and 3) the entrenchment of the Greek Orthodox Church within its practices

Head and neck cancer surgery during the COVID-19 pandemic : An international, multicenter, observational cohort study

Background: The aims of this study were to provide data on the safety of head and neck cancer surgery currently being undertaken during the coronavirus disease 2019 (COVID-19) pandemic. Methods: This international, observational cohort study comprised 1137 consecutive patients with head and neck cancer undergoing primary surgery with curative intent in 26 countries. Factors associated with severe pulmonary complications in COVID-19–positive patients and infections in the surgical team were determined by univariate analysis. Results: Among the 1137 patients, the commonest sites were the oral cavity (38%) and the thyroid (21%). For oropharynx and larynx tumors, nonsurgical therapy was favored in most cases. There was evidence of surgical de-escalation of neck management and reconstruction. Overall 30-day mortality was 1.2%. Twenty-nine patients (3%) tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within 30 days of surgery; 13 of these patients (44.8%) developed severe respiratory complications, and 3.51 (10.3%) died. There were significant correlations with an advanced tumor stage and admission to critical care. Members of the surgical team tested positive within 30 days of surgery in 40 cases (3%). There were significant associations with operations in which the patients also tested positive for SARS-CoV-2 within 30 days, with a high community incidence of SARS-CoV-2, with screened patients, with oral tumor sites, and with tracheostomy. Conclusions: Head and neck cancer surgery in the COVID-19 era appears safe even when surgery is prolonged and complex. The overlap in COVID-19 between patients and members of the surgical team raises the suspicion of failures in cross-infection measures or the use of personal protective equipment. Lay Summary: Head and neck surgery is safe for patients during the coronavirus disease 2019 pandemic even when it is lengthy and complex. This is significant because concerns over patient safety raised in many guidelines appear not to be reflected by outcomes, even for those who have other serious illnesses or require complex reconstructions. Patients subjected to suboptimal or nonstandard treatments should be carefully followed up to optimize their cancer outcomes. The overlap between patients and surgeons testing positive for severe acute respiratory syndrome coronavirus 2 is notable and emphasizes the need for fastidious cross-infection controls and effective personal protective equipment

Head and neck cancer surgery during the COVID-19 pandemic: An international, multicenter, observational cohort study

Background: The aims of this study were to provide data on the safety of head and neck cancer surgery currently being undertaken during the coronavirus disease 2019 (COVID-19) pandemic. Methods: This international, observational cohort study comprised 1137 consecutive patients with head and neck cancer undergoing primary surgery with curative intent in 26 countries. Factors associated with severe pulmonary complications in COVID-19–positive patients and infections in the surgical team were determined by univariate analysis. Results: Among the 1137 patients, the commonest sites were the oral cavity (38%) and the thyroid (21%). For oropharynx and larynx tumors, nonsurgical therapy was favored in most cases. There was evidence of surgical de-escalation of neck management and reconstruction. Overall 30-day mortality was 1.2%. Twenty-nine patients (3%) tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within 30 days of surgery; 13 of these patients (44.8%) developed severe respiratory complications, and 3.51 (10.3%) died. There were significant correlations with an advanced tumor stage and admission to critical care. Members of the surgical team tested positive within 30 days of surgery in 40 cases (3%). There were significant associations with operations in which the patients also tested positive for SARS-CoV-2 within 30 days, with a high community incidence of SARS-CoV-2, with screened patients, with oral tumor sites, and with tracheostomy. Conclusions: Head and neck cancer surgery in the COVID-19 era appears safe even when surgery is prolonged and complex. The overlap in COVID-19 between patients and members of the surgical team raises the suspicion of failures in cross-infection measures or the use of personal protective equipment. Lay Summary: Head and neck surgery is safe for patients during the coronavirus disease 2019 pandemic even when it is lengthy and complex. This is significant because concerns over patient safety raised in many guidelines appear not to be reflected by outcomes, even for those who have other serious illnesses or require complex reconstructions. Patients subjected to suboptimal or nonstandard treatments should be carefully followed up to optimize their cancer outcomes. The overlap between patients and surgeons testing positive for severe acute respiratory syndrome coronavirus 2 is notable and emphasizes the need for fastidious cross-infection controls and effective personal protective equipment

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Λιτανεία του λειψάνου του Αγίου Χαραλάμπη (λεπτομέρεια)

Note:ZakynthosNote:Museum (from Agios Charalampis church at Potami)Στοιχείο:ΖάκυνθοςΣτοιχείο:Μουσείο (από ναό αγίου Χαραλάμπη στο Ποτάμι

Κοράης (Καστρινός) Ιωάννης (1)

Notes: Grandchild of Michail Korais and uncle of Ioannis Korais (2) he was the first teacher of Nikolaos Kantounis. He signed in contracts as Ioannis Korais the hagiographer . We are informed by the codex of the church of Agios Charalampis in Zakynthos that theDescription: ZakynthosDescription: ZakynthosΣτοιχείο: ZακύνθουΣτοιχείο: ΖάκυνθοςΣτοιχείο: Εγγονός του Μιχαήλ Κοράη* και θείος του Ιωάννη Κοράη* (2) υπήρξε ο πρώτος δάσκαλος του Νικολάου Καντούνη(1). Υπέγραψε σε συμβόλαια ως Ιωάννης Κοράης ο αγιογράφος. Από τον κώδικα του ναού του Αγίου Χαραλάμπη στη Ζάκυνθο πληροφορούμεθα ότι η εκτέλεση της μεγάλης Λιτανείας του αγίου Χαραλάμπη (βλ. πιν. 1) άρχισε το 1752 και τελείωσε το 1756, ενώ η αμοιβή του ήταν 25 τσεκίνια. Το 1772 έστειλε επιστολή προς τον Ν. Κουτούζη*, που βρισκόταν στην Κέρκυρα. Με τη διαθήκη του, της 26ης Σεπτεμβρίου 1796, άφησε στον ανηψιό του Ιωάννη Κοράη (2)* … όλα μου τα δισένια, στάμπες μου, κολόρα μου και όλα τα σύνεργα της τέχνης μου, και όλα τα κουάδρα μου που έχω στολισμένο το σπήτι μας, διατί είναι όλα κόπος μου και εξόδειες μου. Πέθανε στις 10 Δεκεμβρίου 1799

Sphenoid sinus aspergilloma with sixth nerve palsy

[No abstract available

Λιτανεία του λειψάνου του Αγίου Χαραλάμπη

Note:ZakynthosNote:Museum (from Agios Charalampis church at Potami)Στοιχείο:ΖάκυνθοςΣτοιχείο:Μουσείο (από ναό αγίου Χαραλάμπη στο Ποτάμι